Corticosteroid

Entity type image
Type: Keyphrase
Name: Corticosteroid
First reported 21 hours ago - Updated 2 hours ago - 2 reports

Five-days of corticosteroid enough for acute COPD

A five-day course of systemic corticosteroid is enough for most patients with acute exacerbations of chronic obstructive pulmonary disease (COPD), according to the results of a Swiss trial.The study, published in JAMA online, 21 May 2013, found that five-day ... [Published Pharmacy Magazine - 2 hours ago]
First reported 3 hours ago - Updated 3 hours ago - 1 reports

Findings on Chronic Inflammatory Demyelinating Polyneuropathy Reported by Investigators at Weill Cornell Medical College

(NewsRx) -- By a News Reporter-Staff News Editor at Immunotherapy Weekly -- Fresh data on Chronic Inflammatory Demyelinating Polyneuropathy are presented in a new report. According to news reporting originating in New York City, New York, by NewsRx editors, ... [Published NewsRX - 3 hours ago]
First reported 8 hours ago - Updated 8 hours ago - 1 reports

Hyperemesis gravidarum - Clinical review

Differentiate HG from morning sickness. By Dr Ciaran Crowe Nausea and vomiting affects 70-85% of all gravid women during the early weeks of pregnancy and usually resolves by 16 weeks' gestation.1,2The extreme end of this condition, hyperemesis gravidarum ... [Published GP Online - 8 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

SIMPONI(R) golimumab Receives FDA Approval for Ulcerative Colitis

(NewsRx) -- By a News Reporter-Staff News Editor at Biotech Business Week -- Janssen Biotech, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved SIMPONI(®) (golimumab) for the treatment of moderately to severely active ulcerative ... [Published NewsRX - 9 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Novartis receives FDA approval for systemic juvenile idiopathic arthritis drug

Novartis has received the FDA approval for Ilaris for the treatment of active systemic juvenile idiopathic arthritis, or SJIA, in patients aged 2 years and older. Ilaris is the first interleukin-1 beta (IL-1 beta) inhibitor approved for SJIA and the only ... [Published Individual.com - 23 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Five-day COPD treatment quells flare-ups, reduces side effects, researchers find

Patients with chronic obstructive pulmonary disease flare-ups do better with a shorter round of prednisone, researchers have found.A team from various Swiss research centers and hospitals conducted a study of more than 300 patients hospitalized with acute ... [Published McKnight's Long Term Care News - 23 hours ago]
First reported May 23 2013 - Updated May 23 2013 - 1 reports

Peripheral airway disease present even in mild asthma

medwireNews: Researchers have found that the alveolar component of exhaled nitric oxide (CalvNO) is associated with lack of asthma control in patients with mild, untreated asthma.The findings suggest that peripheral airway involvement, which is associated ... [Published MedWire News - May 23 2013]
First reported May 23 2013 - Updated May 23 2013 - 1 reports

Central Serous Chorioretinopathy and Topical NSAIDs

Central Serous Chorioretinopathy And Topical NSAIDsThe evidence suggests that NSAIDs should be avoided in patients with CSC.PRADEEP VENKATESH, MDCentral serous chorioretinopathy is characterized by the development of neurosensory detachment of the macula ... [Published Retinal Physician - May 23 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

COHELLP: collaborative randomized controlled trial on corticosteroids in HELLP syndrome

Hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome is one of the most severe forms of preeclampsia and aggravates both maternal and perinatal prognosis. The systematic review available in Cochrane Library compared corticosteroid (dexamethasone, ... [Published 7thSpace - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 2 reports

Exxon Mobil Gives $500K to Oklahoma Relief and 2 Other Dow Movers to Watch

Exxon Mobil Corporation ( NYSE:XOM ): Current price $92.40Exxon Mobil has announced that it will donate $500,000 to the American Red Cross so as to provide disaster relief assistance after the recent tornadoes in Oklahoma and the southwest United States. ... [Published Wall St. Cheat Sheet - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

25 million Americans

About 1 in 12 people (about 25 million) have asthma, and the numbers are increasing every year.About 1 in 2 people (about 12 million) with asthma had an asthma attack in 2008, but many asthma attacks could have been prevented.56 BillionAsthma cost the ... [Published Center for Disease Control and Prevention - May 22 2013]
First reported May 22 2013 - Updated May 22 2013 - 1 reports

Clinical Considerations in Premature Infants

ABSTRACT: Approximately 1 in 10 babies in the United States is born prematurely. Prematurity is the leading cause of death in newborns. Rates of morbidity and mortality are inversely related to gestational age or birthweight. Even infants born 2 or 3 ... [Published U.S.Pharmacist - May 22 2013]

Quotes

...According to news reporting originating in New York City, New York, by NewsRx editors, the research stated, "Chronic inflammatory demyelinating polyneuropathy (CIDP) is a group of idiopathic, acquired, immune-mediated inflammatory demyelinating diseases of the peripheral nervous system. A majority of patients with CIDP respond to 'first-line' treatment with IVIG, plasmapheresis and/or corticosteroids."
...asthma exacerbations," said Tunde Otulana, MD, acting head, Clinical Development and Medical Affairs, Boehringer Ingelheim Pharmaceuticals, Inc. "Finding new advancements for the growing number of people affected by asthma remains one of Boehringer Ingelheim's priorities, and we are encouraged to see additional data reinforcing tiotropium's potential as an additional treatment option for asthma patients who remain symptomatic on current therapies."
...editorial ( ibid ) says the clinical implications are clear: the trial provides convincing evidence that "less is more" for steroid use in COPD. "These findings will enable clinicians to minimise steroid exposure and reduce the risk of steroid-related toxicity."
...for patients living with rare, autoinflammatory conditions," said Timothy Wright, MD, Global Head of Development, Novartis Pharmaceuticals. "We are committed to studying Ilaris in other IL-1 beta mediated inflammatory diseases, including several rare diseases for which treatment options do not currently exist."

More Content

All (652) | News (595) | Reports (15) | Blogs (25) | Audio/Video (0) | Fact Sheets (2) | Press Releases (15)
sort by: Date | Relevance
Five-days of corticosteroid enough for acute COPD [Published Pharmacy Magazine - 2 hours ago]
Findings on Chronic Inflammatory Demyelinating ... [Published NewsRX - 3 hours ago]
Tiotropium Shows Promise Across Wide Range of A... [Published Advance for Respiratory Care & Sleep Medicine - 6 hours ago]
Hyperemesis gravidarum - Clinical review [Published GP Online - 8 hours ago]
SIMPONI(R) golimumab Receives FDA Approval for ... [Published NewsRX - 9 hours ago]
Mepha Pharma AG: New Mepha Pharma AG company pr... [Published TransWorldNews - 19 hours ago]
Five-days of corticosteroid enough for acute COPD [Published PJ Online - 21 hours ago]
Novartis receives FDA approval for systemic juv... [Published Individual.com - 23 hours ago]
Five-day COPD treatment quells flare-ups, reduc... [Published McKnight's Long Term Care News - 23 hours ago]
Managing Hay Fever – Pharmacists Issue Tips to ... [Published Irish Pharmacy Union - May 23 2013]
bitop AG and Alfa Intes signed License and Supp... [Published Open PR - May 23 2013]
Aerocrine Plans Presentation of Data on FeNO te... [Published Individual.com - May 23 2013]
Peripheral airway disease present even in mild ... [Published MedWire News - May 23 2013]
Early Vitrectomy for DME: Does It Have a Role? [Published Retinal Physician - May 23 2013]
Central Serous Chorioretinopathy and Topical NS... [Published Retinal Physician - May 23 2013]
BREO ELLIPTA gains US approval for the treatmen... [Published Pharmacy Choice - May 23 2013]
NOLA Pet Doctors: Rabies Vaccine Reaction [Published WGNO - May 22 2013]
COHELLP: collaborative randomized controlled tr... [Published 7thSpace - May 22 2013]
Natural And Herbal Insomnia Treatment And Remedies [Published PR-Canada.net - May 22 2013]
Exxon Mobil Gives $500K to Oklahoma Relief and ... [Published Wall St. Cheat Sheet - May 22 2013]
Exxon Mobil Gives $500K to Oklahoma Relief and ... [Published Wall St. Cheat Sheet - May 22 2013]
Phase III Success for Boehringer Ingelheim Asth... [Published Genetic Engineering News - May 22 2013]
A Study Comparing Measures of Ventilatory Heter... [Published DukeHealth.org - May 22 2013]
Revitol Rosacea Cream - Get Lasting Rosacea Rel... [Published SBWire - May 22 2013]
Living with osteoarthritis [Published KXLY - May 22 2013]
25 million Americans [Published Center for Disease Control and Prevention - May 22 2013]
Boehringer Ingelheim's tiotropium shows promisi... [Published News-Medical.Net - May 22 2013]
Cardiovascular risk in pediatric-onset rheumato... [Published 7thSpace - May 22 2013]
Probiotics: Even Your Traditional Vet May Now R... [Published Mercola - May 22 2013]
Clinical Considerations in Premature Infants [Published U.S.Pharmacist - May 22 2013]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Exxon Mobil Gives $500K to Oklahoma Relief and ... [Published Wall St. Cheat Sheet - May 22 2013]
Exxon Mobil Corporation ( NYSE:XOM ): Current price $92.40Exxon Mobil has announced that it will donate $500,000 to the American Red Cross so as to provide disaster relief assistance after the recent tornadoes in Oklahoma and the southwest United States. ...
Exxon Mobil Gives $500K to Oklahoma Relief and ... [Published Wall St. Cheat Sheet - May 22 2013]
Exxon Mobil Corporation ( NYSE:XOM ): Current price $92.40 Exxon Mobil has announced that it will donate $500,000 to the American Red Cross so as to provide disaster relief assistance after the recent tornadoes in Oklahoma and the southwest United ...
Phase III Study: Tiotropium Effective In Sympto... [Published Scientific Blogging - Medicine - May 21 2013]
Tiotropium delivered by the Respimat(R) Soft Mist(TM) Inhaler (SMI) increases time to first severe exacerbation and first episode of asthma worsening across a broad spectrum of patients who remain symptomatic despite at least inhaled corticosteroids ...
Horse Racing’s Quest For Safety Fuels Push For ... [Published Think Progress - May 17 2013]
This is the second in a series of posts, corresponding with horse racing’s Triple Crown, examining safety issues facing the sport. Part one appears here . When nine horses leave the gates at Pimlico in the second leg of horse racing’s Triple Crown ...
4 Healthcare Stock Stories For Thursday Investi... [Published Wall St. Cheat Sheet - May 16 2013]
Johnson & Johnson ( NYSE:JNJ ): Closing price $87.45J&J’s Janssen Biotech announced Thursday that the  FDA has cleared Simponi (golimumab) for the treatment of moderately to severely active ulcerative colitis in adult patients who have shown corticosteroid ...
1 2 3 4 5

Press Releases

sort by: Date | Relevance
Aerocrine Announces Presentation of Data on FeN... [Published Business Wire - May 20 2013]
Musculoskeletal Diseases Market - Global Indust... [Published PR inside - May 20 2013]
"PT Sanbe Farma - Strategic SWOT Analysis Revie... [Published PR inside - May 17 2013]
Santarus Announces UCERIS (budesonide) Poster P... [Published Business Wire - May 17 2013]
Soligenix Initiates Phase 1 Clinical Study with... [Published PR Newswire - May 15 2013]
1 2 3
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2013 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.